Is home-brewed heroine next? “When we started this work, you know, there were people and experts in the field who said this was impossible, that it would never be done” Smolke says. Now, just a decade later, she has officially done it

Quick Read

Residents of some neighborhoods in Baltimore have limited access to pharmacies and the medications and supplies that they provide

Read More

Johnson & Johnson has appointed Arthur Caplan, a nationally known bioethicist, to create a panel that will make decisions about patients’ requests for potentially lifesaving medicine, responding to an emotional debate over whether companies should allow desperately ill people to have access to the drugs before they are approved

Quick Read

Homeopathic Oversight

April 22, 2015

In the wake of new evidence of ineffectiveness and potential risks, the FDA is considering changing the way it regulates homeopathic drugs

Read More

New drugs for hepatitis C are a major breakthrough but hugely expensive in rich countries. Pharma giant Gilead will allow cheap copies to be made for poor countries – but only for patients with proof of identification and citizenship and the drug supplies will be closely tracked

Quick Read

Averting a Crisis

February 3, 2014

Experts issue ‘blueprint for action’ to combat shortages of life-saving drugs. Our Yoram Unguru provides background about drug shortages and how they have had a particularly worrisome impact on pediatric oncology

Read More